C07C209/62

Complexes and Ligands
20220025254 · 2022-01-27 ·

The present application provides ligands and fluorescent or luminescent complexes comprising these ligands.

Silylations of aromatic substrates with base-activated organosilanes

The present disclosure describes methods for silylating aromatic organic substrates, and associated chemical systems, said methods comprising or consisting essentially of contacting the aromatic organic substrate with a mixture of (a) at least one organosilane and (b) at least one strong base, under conditions sufficient to silylate the aromatic substrate.

Silylations of aromatic substrates with base-activated organosilanes

The present disclosure describes methods for silylating aromatic organic substrates, and associated chemical systems, said methods comprising or consisting essentially of contacting the aromatic organic substrate with a mixture of (a) at least one organosilane and (b) at least one strong base, under conditions sufficient to silylate the aromatic substrate.

Silylations of aromatic substrates with base-activated organosilanes

The present disclosure describes methods for silylating aromatic organic substrates, and associated chemical systems, said methods comprising or consisting essentially of contacting the aromatic organic substrate with a mixture of (a) at least one organosilane and (b) at least one strong base, under conditions sufficient to silylate the aromatic substrate.

Method for preparing substituted 4-aminoindane derivatives

The present invention relates to a method for preparing substituted 4-aminoindane derivatives of the general formula (I) ##STR00001##
by rearrangement of compounds of the formula (II) in HF, wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, and R.sup.5 have the definitions as specified in the description.

Method for preparing substituted 4-aminoindane derivatives

The present invention relates to a method for preparing substituted 4-aminoindane derivatives of the general formula (I) ##STR00001##
by rearrangement of compounds of the formula (II) in HF, wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, and R.sup.5 have the definitions as specified in the description.

Pinene-derived diisocyanates

A pinene-derived diisocyanate compound, a process for forming a pinene-derived polyurethane, and an article of manufacture that includes the polyurethane are disclosed. The process for forming the polyurethane includes forming a pinene-derived diisocyanate compound, and reacting the pinene-derived diisocyanate compound with a polyol in a polymerization compound.

Pinene-derived diisocyanates

A pinene-derived diisocyanate compound, a process for forming a pinene-derived polyurethane, and an article of manufacture that includes the polyurethane are disclosed. The process for forming the polyurethane includes forming a pinene-derived diisocyanate compound, and reacting the pinene-derived diisocyanate compound with a polyol in a polymerization compound.

Pinene-derived diisocyanates

A pinene-derived diisocyanate compound, a process for forming a pinene-derived polyurethane, and an article of manufacture that includes the polyurethane are disclosed. The process for forming the polyurethane includes forming a pinene-derived diisocyanate compound, and reacting the pinene-derived diisocyanate compound with a polyol in a polymerization compound.

METHOD FOR SYNTHESIZING D3 DOPAMINE RECEPTOR AGONISTS

An improved method for synthesizing a compound according to formula (I) by reaction of a compound of formula (II) with a sulfinamide according to formula (III). The resultant compound is then reduced and hydrolyzed, and optionally alkylated or arylated to arrive at the compound according to formula (I).

##STR00001##